Fecal osteoprotegerin may guide the introduction of second-line therapy in hospitalized children with ulcerative colitis

Francisco A. Sylvester^*, Dan Turner, Andrew Draghi, Krista Uuosoe, Robin McLernon, Kristen Koproske, David R. MacK, Wallace V. Crandall, Jeffrey S. Hyams, Neal S. Leleiko, Anne M. Griffiths

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review